About Skybiotech Healthcare Limited
Data last updated: 14 July 2026
Skybiotech Healthcare Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in business and IT consulting, a part of the broader business process outsourcing sector. Incorporated on 17 October 1983, the company has been in operation for over 43 years.
Registered with ROC Mumbai under CIN L17100MH1983PLC031114. Listed on BSE: 512036.
Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹1.92 Cr. Formerly known as Kapil Cotex Ltd. It is led by directors including Poonam Prakash Rathi and Rakesh Ramswaroop Somani.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.
As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹7.1 Cr, a growth of 0.65% compared to the previous year. The net worth stands at ₹9.25 Cr (down 12.19% YoY). Total assets are valued at ₹19.44 Cr (down 3.27% YoY).
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website satellitecorporate.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressShop No. 276 Dreams Mall L. B. S. Marg Near Bhandup Railway Station Bhandup (W, Est), Mumbai, Maharashtra, India – 400078
-
IndustryBusiness Outsourcing, Business & IT Consulting
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Skybiotech Healthcare Limited
Skybiotech Healthcare Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L21001MH1983PLC031114, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L21001MH1983PLC031114 | Current |
| L17100MH1983PLC031114 | Previous |
| U17100MH1983PLC031114 | Previous |
Business Activity of Skybiotech Healthcare Limited
Skybiotech Healthcare Limited is engaged in the principal business activity of manufacturing, with detailed activities including textile, leather and other apparel products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C2 | Textile, leather and other apparel products | Locked |
Business activity turnover details for Skybiotech Healthcare Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Skybiotech Healthcare Limited
Skybiotech Healthcare Limited is audited by SPD AND ASSOCIATES (ICAI peer reviewed, certificate valid till 2026-11-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| SPD AND ASSOCIATES (ICAI peer reviewed, certificate valid till 2026-11-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Skybiotech Healthcare Limited
Skybiotech Healthcare Limited is currently managed by 6 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Prakash Rathi | Managing Director | 14 Feb 2005 | 21 Years 5 Months | Current |
| Rakesh Ramswaroop Somani | Director | 04 Sep 2017 | 8 Years 10 Months | Current |
| Yogesh Nandlal Chandak | Director | 14 Feb 2005 | 21 Years 5 Months | Current |
| Jagdish Manohar Mantri | Director | 07 Sep 2017 | 8 Years 10 Months | Current |
| Prakashchandra Rathi | Director | 28 Jun 2003 | 23 Years 0 Months | Current |
| Vijay Sitaram Chitlange | Director | 28 Aug 2025 | 0 Years 10 Months | Current |
Financials of Skybiotech Healthcare Limited FY 2026 filings available
Skybiotech Healthcare Limited reported revenue of ₹7.1 Cr (up 0.65% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹7.1 Cr | ₹7.05 Cr |
| Other Income | ₹30.6 Lakh | ₹38.27 Lakh |
| Total Income | ₹7.4 Cr | ₹7.43 Cr |
| Cost of Materials Consumed | ₹3.09 Cr | ₹3.67 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 |
| Changes in Inventories | ₹81.53 Lakh | -₹5.6 Lakh |
| Employee Benefit Expense | ₹1.76 Cr | ₹1.96 Cr |
| Finance Costs | ₹2.11 Lakh | ₹1.21 Lakh |
| Depreciation & Amortisation | ₹47.86 Lakh | ₹54.22 Lakh |
| Other Expenses | ₹2.9 Cr | ₹3.72 Cr |
| Total Expenses | ₹9.07 Cr | ₹9.86 Cr |
| Profit Before Exceptional Items & Tax | -₹1.67 Cr | -₹2.43 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | -₹1.67 Cr | -₹2.43 Cr |
| Total Tax Expense | -₹54.98 Lakh | -₹5.61 Lakh |
| Net Profit | -₹1.12 Cr | -₹2.37 Cr |
| attributable to Owners | -₹99.27 Lakh | ₹0 |
| attributable to NCI | -₹29.06 Lakh | ₹0 |
| Other Comprehensive Income | -₹16.65 Lakh | -₹34.7 Lakh |
| Total Comprehensive Income | -₹1.28 Cr | -₹2.72 Cr |
| EBITDA (computed) | -₹1.17 Cr | -₹1.87 Cr |
| Basic EPS | ₹-6.70 | ₹-14.19 |
| Diluted EPS | ₹-6.70 | ₹-14.19 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹19.44 Cr | ₹20.1 Cr |
| Non-current Assets | ₹18.12 Cr | ₹18.18 Cr |
| Current Assets | ₹1.33 Cr | ₹1.92 Cr |
| Property, Plant & Equipment | ₹8.37 Cr | ₹8.85 Cr |
| Inventories | ₹80.09 Lakh | ₹1.59 Cr |
| Trade Receivables | ₹1.11 Cr | ₹42.46 Lakh |
| Cash & Equivalents | -₹59.44 Lakh | -₹26.91 Lakh |
| Equity (Net Worth) | ₹9.25 Cr | ₹10.54 Cr |
| Equity Share Capital | ₹1.92 Cr | ₹1.92 Cr |
| Borrowings (Non-current) | ₹8.25 Cr | ₹7.01 Cr |
| Borrowings (Current) | ₹16.67 Lakh | ₹18.97 Lakh |
| Total Debt (computed) | ₹8.42 Cr | ₹7.2 Cr |
| Current Liabilities | ₹1.94 Cr | ₹2.55 Cr |
| Total Liabilities | ₹10.19 Cr | ₹9.56 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | -₹1.52 Cr | -₹1.04 Cr |
| Investing Cash Flow | ₹2.02 Lakh | -₹9.63 Cr |
| Financing Cash Flow | ₹1.17 Cr | ₹1.24 Cr |
| Capital Expenditure | ₹22,000 | ₹0 |
| Free Cash Flow (computed) | -₹1.52 Cr | -₹1.04 Cr |
| Dividends Paid | ₹0 | ₹0 |
| Net Change in Cash | -₹32.53 Lakh | -₹9.43 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1.83 Cr | ₹96.27 Lakh | ₹1.92 Cr | ₹2.39 Cr | ₹1.02 Cr | ₹2.52 Cr | ₹1.6 Cr | ₹2.39 Cr |
| Other Income | ₹15.31 Lakh | ₹7.85 Lakh | ₹3.98 Lakh | ₹3.46 Lakh | -₹18.38 Lakh | ₹14.71 Lakh | ₹3.68 Lakh | ₹3.46 Lakh |
| Total Income | ₹1.98 Cr | ₹1.04 Cr | ₹1.96 Cr | ₹2.42 Cr | ₹83.46 Lakh | ₹2.67 Cr | ₹1.64 Cr | ₹2.42 Cr |
| Cost of Materials Consumed | ₹96.95 Lakh | ₹54.9 Lakh | ₹33.34 Lakh | ₹1.24 Cr | ₹91.32 Lakh | ₹85.64 Lakh | ₹46.64 Lakh | ₹1.24 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹37.1 Lakh | ₹0 | ₹59.65 Lakh | -₹15.22 Lakh | -₹11.23 Lakh | ₹45.04 Lakh | -₹22.6 Lakh | -₹15.22 Lakh |
| Employee Benefit Expense | ₹43.45 Lakh | ₹36.46 Lakh | ₹57.44 Lakh | ₹38.9 Lakh | ₹41.73 Lakh | ₹65.5 Lakh | ₹37.29 Lakh | ₹38.9 Lakh |
| Finance Costs | ₹49,000 | ₹44,000 | ₹47,000 | ₹71,000 | -₹23.17 Lakh | ₹10.65 Lakh | ₹13.47 Lakh | ₹71,000 |
| Depreciation & Amortisation | ₹12.15 Lakh | ₹11.9 Lakh | ₹11.84 Lakh | ₹11.97 Lakh | ₹14.67 Lakh | ₹14.43 Lakh | ₹12.56 Lakh | ₹11.97 Lakh |
| Other Expenses | ₹93.57 Lakh | ₹48.89 Lakh | ₹63.85 Lakh | ₹83.54 Lakh | ₹88.57 Lakh | ₹87.05 Lakh | ₹95.91 Lakh | ₹83.54 Lakh |
| Total Expenses | ₹2.84 Cr | ₹1.53 Cr | ₹2.27 Cr | ₹2.44 Cr | ₹2.02 Cr | ₹3.08 Cr | ₹1.83 Cr | ₹2.44 Cr |
| Profit Before Exceptional Items & Tax | -₹85.36 Lakh | -₹48.47 Lakh | -₹30.96 Lakh | -₹1.87 Lakh | -₹1.18 Cr | -₹41.47 Lakh | -₹19.23 Lakh | -₹1.87 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹85.36 Lakh | -₹48.47 Lakh | -₹30.96 Lakh | -₹1.87 Lakh | -₹1.18 Cr | -₹41.47 Lakh | -₹19.23 Lakh | -₹1.87 Lakh |
| Total Tax Expense | -₹54.98 Lakh | ₹0 | ₹0 | ₹0 | -₹10.12 Lakh | -₹1.99 Lakh | ₹5.52 Lakh | ₹0 |
| Net Profit | -₹30.38 Lakh | -₹48.47 Lakh | -₹30.96 Lakh | -₹1.87 Lakh | -₹1.08 Cr | -₹39.48 Lakh | -₹24.75 Lakh | -₹1.87 Lakh |
| attributable to Owners | -₹48.11 Lakh | -₹24.77 Lakh | -₹24.63 Lakh | -₹1.77 Lakh | ₹0 | -₹47.94 Lakh | - | -₹1.77 Lakh |
| attributable to NCI | -₹8.56 Lakh | -₹11.56 Lakh | -₹8.84 Lakh | -₹10,000 | ₹0 | -₹10.72 Lakh | - | -₹10,000 |
| Other Comprehensive Income | -₹26.29 Lakh | ₹12.14 Lakh | -₹9.08 Lakh | ₹6.58 Lakh | -₹1.54 Cr | -₹19.18 Lakh | ₹1.29 Cr | ₹6.58 Lakh |
| Total Comprehensive Income | -₹56.67 Lakh | -₹36.33 Lakh | -₹40.04 Lakh | ₹4.71 Lakh | -₹2.62 Cr | -₹58.66 Lakh | ₹1.05 Cr | ₹4.71 Lakh |
| EBITDA (computed) | -₹72.72 Lakh | -₹36.13 Lakh | -₹18.65 Lakh | ₹10.81 Lakh | -₹1.27 Cr | -₹16.39 Lakh | ₹6.8 Lakh | ₹10.81 Lakh |
| Basic EPS | ₹-2.96 | ₹-1.29 | ₹-1.29 | ₹0.25 | ₹-13.68 | ₹-3.06 | ₹5.46 | ₹0.25 |
| Diluted EPS | ₹-2.96 | ₹-1.29 | ₹-1.29 | ₹0.25 | ₹-13.68 | ₹-3.06 | ₹5.46 | ₹0.25 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Income | ₹6.69 Lakh | ₹18.12 Lakh | ₹2 Cr | ₹5.42 Lakh | ₹2.27 Lakh | ₹2.08 Lakh | ₹6.62 Lakh | ₹3.67 Lakh |
| Total Income | ₹6.69 Lakh | ₹18.12 Lakh | ₹2 Cr | ₹5.42 Lakh | ₹2.27 Lakh | ₹2.08 Lakh | ₹6.62 Lakh | ₹3.67 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹1.44 Lakh | ₹1.44 Lakh | ₹1.44 Lakh | ₹1.16 Lakh | ₹1.44 Lakh | ₹1.56 Lakh | ₹96,000 | ₹6,000 |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹1,000 | ₹2,000 | ₹8,000 | ₹15,000 | ₹23,000 | ₹24,000 | ₹32,000 | ₹43,000 |
| Other Expenses | ₹11.24 Lakh | ₹9.07 Lakh | ₹11.21 Lakh | ₹4.84 Lakh | ₹4.38 Lakh | ₹5.1 Lakh | ₹9.09 Lakh | ₹5.98 Lakh |
| Total Expenses | ₹12.69 Lakh | ₹10.53 Lakh | ₹12.73 Lakh | ₹6.15 Lakh | ₹6.05 Lakh | ₹6.9 Lakh | ₹10.37 Lakh | ₹6.47 Lakh |
| Profit Before Exceptional Items & Tax | -₹6 Lakh | ₹7.59 Lakh | ₹1.88 Cr | -₹73,000 | -₹3.78 Lakh | -₹4.82 Lakh | -₹3.75 Lakh | -₹2.8 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹6 Lakh | ₹7.59 Lakh | ₹1.88 Cr | -₹73,000 | -₹3.78 Lakh | -₹4.82 Lakh | -₹3.75 Lakh | -₹2.8 Lakh |
| Total Tax Expense | ₹3,000 | ₹1.63 Lakh | ₹33.97 Lakh | ₹0 | ₹0 | -₹1,000 | ₹2,000 | ₹4,000 |
| Net Profit | -₹6.03 Lakh | ₹5.96 Lakh | ₹1.54 Cr | -₹73,000 | -₹3.78 Lakh | -₹4.81 Lakh | -₹3.77 Lakh | -₹2.84 Lakh |
| Other Comprehensive Income | -₹16.65 Lakh | -₹34.7 Lakh | -₹86.26 Lakh | -₹23.45 Lakh | ₹50.84 Lakh | ₹98.7 Lakh | -₹33.5 Lakh | ₹8.27 Lakh |
| Total Comprehensive Income | -₹22.68 Lakh | -₹28.74 Lakh | ₹67.27 Lakh | -₹24.18 Lakh | ₹47.06 Lakh | ₹93.89 Lakh | -₹37.27 Lakh | ₹5.43 Lakh |
| EBITDA (computed) | -₹5.99 Lakh | ₹7.61 Lakh | ₹1.88 Cr | -₹58,000 | -₹3.55 Lakh | -₹4.58 Lakh | -₹3.43 Lakh | -₹2.37 Lakh |
| Basic EPS | ₹-1.18 | ₹-1.50 | ₹3.67 | ₹-2.32 | ₹4.52 | ₹9.03 | ₹-3.58 | ₹0.52 |
| Diluted EPS | ₹-1.18 | ₹-1.50 | ₹3.67 | ₹-2.32 | ₹4.52 | ₹9.03 | ₹-3.58 | ₹0.52 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹12.42 Cr | ₹12.62 Cr | ₹11.53 Cr | ₹4.06 Cr | ₹4.37 Cr | ₹3.7 Cr | ₹2.67 Cr | ₹3.11 Cr |
| Non-current Assets | ₹12.25 Cr | ₹12.48 Cr | ₹2.93 Cr | ₹4.04 Cr | ₹4.36 Cr | ₹3.68 Cr | ₹2.63 Cr | ₹3.08 Cr |
| Current Assets | ₹16.51 Lakh | ₹14.57 Lakh | ₹8.6 Cr | ₹2.07 Lakh | ₹1.59 Lakh | ₹1.9 Lakh | ₹3.62 Lakh | ₹3.05 Lakh |
| Property, Plant & Equipment | ₹8,000 | ₹28,000 | ₹48,000 | ₹55,000 | ₹70,000 | ₹94,000 | ₹1.12 Lakh | ₹1.45 Lakh |
| Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Trade Receivables | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹13,000 | ₹0 | ₹47,000 |
| Cash & Equivalents | ₹66,000 | -₹1.57 Lakh | ₹8.43 Cr | ₹1.75 Lakh | ₹1.17 Lakh | ₹1.77 Lakh | ₹1.12 Lakh | ₹2.58 Lakh |
| Equity (Net Worth) | ₹11.55 Cr | ₹11.78 Cr | ₹10.83 Cr | ₹3.49 Cr | ₹3.72 Cr | ₹3.22 Cr | ₹2.51 Cr | ₹2.83 Cr |
| Equity Share Capital | ₹1.92 Cr | ₹1.92 Cr | ₹1.92 Cr | ₹1.04 Cr | ₹1.04 Cr | ₹1.04 Cr | ₹1.04 Cr | ₹1.04 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Current Liabilities | ₹74.91 Lakh | ₹67.11 Lakh | ₹0 | ₹72,000 | ₹83,000 | ₹92,000 | ₹71,000 | ₹2.72 Lakh |
| Total Liabilities | ₹86.54 Lakh | ₹84.29 Lakh | ₹69.4 Lakh | ₹57.22 Lakh | ₹65.16 Lakh | ₹48.3 Lakh | ₹15.2 Lakh | ₹28.36 Lakh |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹0 | ₹30.01 Lakh | -₹1.34 Cr | -₹35.07 Lakh | ₹60.96 Lakh |
| Investing Cash Flow | ₹2.23 Lakh | -₹9.3 Cr | ₹3.63 Cr | ₹35.66 Lakh | -₹61.56 Lakh |
| Financing Cash Flow | ₹0 | ₹55.13 Lakh | ₹6.13 Cr | ₹0 | ₹0 |
| Capital Expenditure | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Free Cash Flow (computed) | ₹0 | ₹30.01 Lakh | -₹1.34 Cr | -₹35.07 Lakh | ₹60.96 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹2.23 Lakh | -₹8.45 Cr | ₹8.42 Cr | ₹59,000 | -₹59,600 |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Income | ₹2.27 Lakh | -₹8,000 | ₹1.54 Lakh | ₹2.96 Lakh | -₹19.71 Lakh | ₹16,000 | ₹2.25 Lakh | ₹35.42 Lakh |
| Total Income | ₹2.27 Lakh | -₹8,000 | ₹1.54 Lakh | ₹2.96 Lakh | -₹19.71 Lakh | ₹16,000 | ₹2.25 Lakh | ₹35.42 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹36,000 | ₹36,000 | ₹36,000 | ₹36,000 | ₹36,000 | ₹36,000 | ₹36,000 | ₹36,000 |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | -₹2,000 | ₹1,000 | ₹1,000 | ₹1,000 | -₹3,000 | ₹2,000 | ₹1,000 | ₹2,000 |
| Other Expenses | ₹1.2 Lakh | ₹5.96 Lakh | ₹0 | ₹4.08 Lakh | ₹3.84 Lakh | ₹26,000 | ₹95,000 | ₹4.02 Lakh |
| Total Expenses | ₹1.54 Lakh | ₹6.33 Lakh | ₹37,000 | ₹4.45 Lakh | ₹4.17 Lakh | ₹64,000 | ₹1.32 Lakh | ₹4.4 Lakh |
| Profit Before Exceptional Items & Tax | ₹73,000 | -₹6.41 Lakh | ₹1.17 Lakh | -₹1.49 Lakh | -₹23.88 Lakh | -₹48,000 | ₹93,000 | ₹31.02 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹73,000 | -₹6.41 Lakh | ₹1.17 Lakh | -₹1.49 Lakh | -₹23.88 Lakh | -₹48,000 | ₹93,000 | ₹31.02 Lakh |
| Total Tax Expense | ₹3,000 | ₹0 | ₹0 | ₹0 | -₹4.14 Lakh | ₹0 | ₹19,000 | ₹5.58 Lakh |
| Net Profit | ₹70,000 | -₹6.41 Lakh | ₹1.17 Lakh | -₹1.49 Lakh | -₹19.74 Lakh | -₹48,000 | ₹74,000 | ₹25.44 Lakh |
| Other Comprehensive Income | -₹26.29 Lakh | ₹12.14 Lakh | -₹9.08 Lakh | ₹6.58 Lakh | -₹1.54 Cr | -₹19.18 Lakh | ₹1.29 Cr | ₹8.86 Lakh |
| Total Comprehensive Income | -₹25.59 Lakh | ₹5.73 Lakh | -₹7.91 Lakh | ₹5.09 Lakh | -₹1.73 Cr | -₹19.66 Lakh | ₹1.3 Cr | ₹34.3 Lakh |
| EBITDA (computed) | ₹71,000 | -₹6.4 Lakh | ₹1.18 Lakh | -₹1.48 Lakh | -₹23.91 Lakh | -₹46,000 | ₹94,000 | ₹31.04 Lakh |
| Basic EPS | ₹-1.34 | ₹0.30 | ₹0.00 | ₹0.27 | ₹-9.06 | ₹-1.03 | ₹6.79 | ₹1.79 |
| Diluted EPS | ₹-1.34 | ₹0.30 | ₹0.00 | ₹0.27 | ₹-9.06 | ₹-1.03 | ₹6.79 | ₹1.79 |
Shareholding Pattern of Skybiotech Healthcare Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 63.48%, retail and other public shareholders hold 36.52% of Skybiotech Healthcare Limited. The company had 610 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 63.48% | 63.48% | 63.48% | 63.48% | 63.48% | 62.71% |
| Public | 36.52% | 36.52% | 36.52% | 36.52% | 36.52% | 37.29% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 63.48% | 63.48% | 62.71% |
| Public | 36.52% | 36.52% | 37.29% |
| Promoter change (YoY, %pts) | +0.00 | +0.77 | - |
Charges & Borrowings Skybiotech Healthcare Limited
Skybiotech Healthcare Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Skybiotech Healthcare Limited
View historical data on people associated with Skybiotech Healthcare Limited, including employment history and EPFO contributions.
Employee and EPFO history for Skybiotech Healthcare Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Skybiotech Healthcare Limited
GST registrations and filing compliance for Skybiotech Healthcare Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Skybiotech Healthcare Limited
Credit ratings, litigation, and regulatory alerts for Skybiotech Healthcare Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Skybiotech Healthcare Limited
MSME payment history for Skybiotech Healthcare Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Skybiotech Healthcare Limited
Corporate group structure for Skybiotech Healthcare Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Skybiotech Healthcare Limited
MCA filings and documents for Skybiotech Healthcare Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Skybiotech Healthcare Limited
Frequently Asked Questions about Skybiotech Healthcare Limited
Skybiotech Healthcare Limited is an active public limited company in the business outsourcing sector based in Mumbai, Maharashtra, India. It was incorporated on 17 October 1983 (43+ years old) and is registered under CIN L21001MH1983PLC031114. Listed on BSE: 512036.
Skybiotech Healthcare Limited reported revenue of ₹7.1 Cr for FY 2026 (up 0.65% YoY) based on consolidated BSE filings.
The current directors of Skybiotech Healthcare Limited are:
- Poonam Prakash Rathi - Managing Director
- Rakesh Ramswaroop Somani - Director
- Yogesh Nandlal Chandak - Director
- Jagdish Manohar Mantri - Director
- Prakashchandra Rathi - Director
- Vijay Sitaram Chitlange - Director
The primary industry of Skybiotech Healthcare Limited is business outsourcing. The company specifically operates in business and IT consulting. The company is currently active in this sector.
Yes. Skybiotech Healthcare Limited is listed on BSE with code 512036.
Skybiotech Healthcare Limited can be reached at the registered office: Shop No. 276 Dreams Mall L. B. S. Marg Near Bhandup Railway Station Bhandup W, Est, Mumbai, Maharashtra, India – 400078, or through the website satellitecorporate.com.